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ABSTRACT 
Objective:  Binding affinity towards DNA for small molecules is very important in the development of new therapeutic reagents. Interaction 
between N-Arylhydroxamic acid derivatives N-p-Tolyl-4-Ethoxybenzohydroxamic acid (p-TEBHA) and N-o- Tolyl-4-Ethoxybenzohydroxamic Acid 
(o-TEBHA), with calf thymus DNA (CT DNA) were studied by UV–visible absorption, fluorescence,  viscosity measurement and molecular docking.  
Methods:  The absorption and emission spectra of DMSO solution of hydroxamic acid derivatives were studied for their binding activity with calf-
thymus DNA by titration with increasing amount hydroxamic acids. Docking was performed by HEX software. 
Results:  Fluorescent spectra showed that CT DNA quenches the emission spectra of p-TEBHA & o-TEBHA with binding constant 1.6 х 108 M-1 and 
4.3 х 103 M-1
Conclusion:  Investigated hydroxamic acid derivatives are found to be strong DNA binders and seem to have promising drug like nature. 
 respectively. Competitive study with ethidium bromide (EB) indicates that p-TEBHA can displace the DNA-bound EB suggesting strong 
competition with EB whereas o-TEBHA does not displace the DNA-bounded Ethidium bromide effectively. UV study of the interaction of the 
complexes with calf-thymus DNA has shown that the hydroxamic acid derivatives can bind with CT DNA. The docking studies were used to predict 
the mode of interaction of the drug with DNA. It was observed that as far as binding strength was concerned the computational results 
complemented the experimental results.  
Keywords:  Fluorescence, Binding constant, Viscosity,  Hydroxamic acid,  Interaction with DNA. 
 
INTRODUCTION 
Significant progress has been made over the past few years in 
studies of drug-DNA interactions [1]. DNA is one of the most 
important bio-macromolecules and essential for several biological 
processes [2]. It contains all the genetic information for cellular 
function. However,  these molecules are prone to be damaged under 
various conditions including,  interactions with some molecules. 
This damage may lead to various pathological changes in living 
organisms. The binding interaction of small molecules with DNA is 
of interest for both therapeutic and scientific reasons. The 
interaction of small molecules with DNA may be summarized as an 
electrostatic interaction that extends the negatively charged 
phosphates outside the DNA double helix, an interaction with 
grooves of DNA,  and an intercalation in which the base pairs of DNA 
unwind to accommodate the intercalating agent [3, 4]. 
Hydroxamic acids have attracted considerable attention due to their 
pharmacological,  toxicological and pathological properties over the 
past decade [5-10]. They contain a pharmacophoric structural part 
(-NOH. C=O) and Hydrogen Bond Donor (HBD) and Hydrogen Bond 
Acceptor (HBA) capability to bind with receptors [11-15]. 
Derivatives of N-arylhydroxamic acids have also been proved as 
antitumor/cancer and antioxidant agents [16-19]. Within this 
context, here we determined the DNA binding interaction of 
following hydroxamic acids:  N-p-Tolyl-4-Ethoxybenzohydroxamic 
Acid (p-TEBHA) and N-o- Tolyl-4-Ethoxybenzohydroxamic Acid (o-
TEBHA). 
MATERIALS AND METHODS 
Apparatus 
Fluorescence measurements were performed with a Cary Eclipse 
fluorescence spectrophotometer Varian USA,  equipped with a xenon 
flash lamp using a 1.0 cm quartz cell. The absorption spectra were 
measured on a Biospectrum BL-198 Elico India,  spectrophotometer 
using a 1.0 cm quartz cells. Viscosity measurements were carried out 
using an Ubbleohole viscometer maintained at a constant 
temperature of 25±0.2 o
By the reported standard procedure [20-24], the preparation of p-
TEBHA and o-TEBHA was done. The purity of synthesized 
compounds was ascertained by determining their melting point,  
elementary and IR analysis and has been enlisted in table 1. 
C and flow time was measured with a digital 
stop watch. pH measurements were carried out with a Eutech 
instrument,  Oakton pH meter. 
Reagents  
  
Table 1: Characterization of p-TEBHA and o-TEBHA. 
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Calf thymus DNA (Sigma Aldrich chem., Co. USA) was used without 
further purification,  and its stock solution was prepared by 
dissolving an appropriate amount of DNA into doubly distilled water 
and stored at 4oC. The concentration of DNA in stock solution was 
determined by UV absorption at 260 nm using a molar absorbance 
coefficient ϵ260  = 6600 L mol-1 cm-1. The absorbance ratio (A260/A280) 
was determined for the characterization of the DNA molecules. The 
solution gave a ratio of > 1.8 at A260/A280,  indicating that DNA was 
sufficiently free from protein. Ethidium bromide (EB) stock solution 
(100 µM) was prepared by dissolving its crystal (Sigma Aldrich) in 
doubly distilled water and stored in a cool and dark place. All 
chemicals were of analytical reagent grade and doubly distilled 
water was used throughout the experimentation. 
Procedure 
UV spectroscopic method 
The UV titrations of the complex were performed using a fixed 
concentration of the compound (50 µM) to which increments of the 
DNA stock solution (25-125µM) was added. The resulting solutions 
were recorded in the wavelength range of 190-340 nm at 298.15 K. 
Fluorescence spectroscopic method 
The fluorescence emission spectra were measured in the 
wavelength range of 210-600 nm with exciting wavelength 220 nm. 
The competitive interactions between the EB and N-arylhydroxamic 
acids with Ct-DNA (20 µl) were titrated with increasing amount of 
compound (0-210µM) solution at wavelength 510 to 700 nm [4]. 
Viscosity method 
Viscosity measurements were performed at room temperature. A 
mixture of 20 ml (1.0 ml DNA solution in 19.0 ml buffer) was taken 
in viscometer and flow time noted. An appropriate amount of 
compound solution was then added into the viscometer to give a 
certain r ([HA]/[DNA]) while keeping the DNA concentration 
constant. The data were presented as (η/η0)1/3 versus r,  where η 
and η0  are the viscosity of DNA in the presence and absence of the 
compounds,  respectively [25].  
Molecular Docking 
Docking is able to discriminate "good" or "bad" ligands. Docking is a 
method which predicts the preferred orientation of one molecule to 
a second when bound to each other to form a stable complex. 
Knowledge of the preferred orientation in turn may be used to 
predict the strength of association or binding affinity between two 
molecules. The ligand was drawn in the cdx format and converted 
into PDB format. The DNA duplex receptor structure was obtained 
from Protein Data Bank (PDB. No. ID1R2L) with 12 base pairs with 
sequence CCATAATTTACC:  CCTATGAAATCC running in 3’–5’ 
directions. Hex, was used to calculate DNA-hydroxamic acids 
docking assuming ligand as rigid.  
RESULTS AND DISCUSSION 
UV absorption studies 
The interaction of p-TEBHA and o-TEBHA with CT DNA has been 
studied with UV spectroscopy in order to investigate the possible 
binding modes to CT DNA and to calculate the binding constants to 
CT DNA (Kb
A hyperchromism has been attributed to the presence of groove 
surface binding along outside of DNA helix [26]. In order to illustrate 
the binding strength of the compound with DNA, the intrinsic 
binding constant,  K
). The absorption spectra were recorded for fixed 
concentration of p-TEBHA and o-TEBHA with increasing 
concentration of DNA. A “hyperchromic effect” was observed for 
increasing concentration of DNA as shown in Fig.1.  
b
 
 was determined from the spectral data using 











where,  [DNA] is the concentration of DNA,  A0 and A are the 
absorbance of the complex in the free and fully bound state and 𝛆𝛆𝛆𝛆 
and 𝜺𝜺𝒃𝒃 correspond to the extinction coefficient,  respectively. Kb was 
calculated from a plot of A0/ (A-A0) versus 1/ [DNA]. The value of 
intrinsic binding constant,  Kb
 
 
 for p-TEBHA was found to be higher 
than o-TEBHA on binding with DNA (table.2).  
 
Fig. 1: UV absorbtion spectra of (A) p-TEBHA and (B) o-TEBHA 
in DMSO solution (50 µM) in the presence of CT DNA (in 5 mM 
Tris–HCl buffer at pH 7.4) having Concentrations (µl), (a) 0.00 
(b) 25 (c) 45 (d) 65 (e) 85 (f) 105 (g) 125 at 298.15 K. The 
arrows shows the hypochromic (A) and hyperchromic (B) 
changes due to interaction of hydroxamic acids with ct-DNA 
respectively.
 
Table 2: Binding parameters of p-TEBHA and o-TEBHA with Calf thymus DNA. 
S. No. Compound Name *UV-Binding Constant (Kb
 
) **F-Binding Constant (Kb
 




1 p-TEBHA 1.3 х 106 M 1.6 х 10-1  8 M 2.13 -1 0.034 
2 o-TEBHA 3.9 х 105 M 4.3 х 10-1 3 M 0.94 -1 0.028 
*Binding Constant from UV Spectrophotometer, **F-Binding Constant from fluorescence Spectrophotometer 
 
 
Fluorescence spectral studies 
The fluorescence titration spectra have been confirmed to be 
effective for characterizing the binding mode of the compounds with 
DNA. Fixed amount of p-TEBHA and o-TEBHA was titrated with 
increasing amount of DNA. A result of emission titration for 
compound with DNA at 298 K is illustrated in Fig. 2. The 
fluorescence intensity of the compound is quenched steadily with 
the increasing concentration of DNA. This quenching of compound 
by DNA indicates that compound had a strong interaction with DNA 
[1]. The binding constant (Kb
Log (F
) and the number of binding sites (n) 
can be estimated by the following equation (2), 
0 – F)/F = log Kb
The value of K
 + n log [Q]    (2) 
b was obtained from inset Fig. 2, through the intercept 
of the plot of log [(F0-F)/F] versus log [Q]. [Q] is the concentration of 
quenching reagent and F0  is the fluorescence intensity of the 
compound alone,  while F is the fluorescence intensity of compound 
with the presence of DNA. Kb
 
 and n of complex at 298.15 K has been 




Fig. 2: The fluorescence spectral intensity of (A) p-TEBHA and 
(B) o-TEBHA in DMSO solution (50 µM) in the presence of CT 
DNA (in 5 mM Tris–HCl buffer at pH 7.4) having Concentrations 
(µl), (a) 0.00 (b) 25 (c) 45 (d) 65 (e) 85 (f) 105 (g) 125 at 298.15 
K. The arrows show the hypochromic for (A) and (B) changes 
due to interaction of hydroxamic acids with CT DNA. Inset Plot 
of log [Q] versus log (F0-F)/F. 
 
Ethidium bromide displacement method 
A competitive binding experiment using EB as a probe was carried 
out in which EB (3,8-diamino-5-ethyl-6-phenylphenanthrium 
bromide) is an intercalator that gives significant increase in 
fluorescence emission when bound to DNA and it can be quenched 
by the addition of second DNA binding molecule by either replacing 
the EB and/or by accepting the excited-state electron of the EB 
through a photoelectron transfer mechanism and an enhancement of 
emission intensity when EB bound intercalatively to DNA [27-30]. 
The emission spectra of EB–DNA system in the presence and 
absence of compounds are shown in Fig. 3. The quenching plots of 
I0/I vs. [Comp]/[DNA] (inset Fig. 3) are in good agreement with the 
linear Stern–Volmer equation with Ksv
 
 values of 0.034 and 0.028 for 




Fig. 3: Emission spectra of EB bound to DNA in the presence of 
(A) p-TEBHA and (B) o-TEBHA in 5 mM Tris–HCl buffer at pH 
7.4. The arrows show the intensity changes upon increasing 
concentrations of the hydroxamic acids. Inset plots of I0
 
/I vs. 
[Compound]/[DNA] for experimental data points and full line 
for linear fitting of the data. 
Viscometric studies 
To confirm the DNA binding modes,  viscosity studies were carried 
out. Viscosity experiment is an effective tool to determine the 
binding mode of small molecules with DNA. Hydrodynamic 
measurement (viscosity) that are sensitive to length change are 
regarded as the least ambiguous most critical test of the binding 
model in a solution in the absence of any spectroscopic data [26]. A 
classical intercalation binding demands the space of adjacent base 
pairs to be large enough to accommodate the bound ligand and to 
evaluate the double helix,  resulting in an increase of DNA viscosity. 
As can be seen from Fig. 4, upon increasing the concentration of p-
TEBHA and o-TEBHA the relative viscosity of DNA increases [1] 
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Fig. 4: A linear increase in relative viscosity of CT DNA (η/ηo)1/3
 
 
in buffer in 5 mM Tris–HCl at pH 7.4 in the presence of (A) p-
TEBHA and (B) o-TEBHA at increasing amounts (r) at 298 K. 
Molecular Docking 
Docking studies of p-TEBHA and o-TEBHA with DNA were carried 
out by hex 6.0 software. The structure of the H. A–DNA complex was 
predicted [31]. In the present work docking studies also predict that 
in the p-TEBHA-DNA complex,  planar ring structure intercalates 
between nitrogenous base pairs of DNA while o-TEBHA act like 
groove binder which bind to the groove of DNA double helix as 
shown in Fig.5. Thus the prediction by the computational work 










The binding interaction between p-TEBHA and o- TEBHA and calf-
thymus DNA has been investigated using fluorescence, UV 
absorption and viscosity methods. Experimental results indicate that 
the binding strength of the complexes with CT DNA calculated with 
UV and fluorescence spectroscopic titrations have shown that p-
TEBHA exhibits the highest Kb value 1.6 х 108 M-1
ACKNOWLEDGEMENT 
 in fluorescence 
spectra among the compound examined which shows intercalation 
mode of binding. Decrease in emission intensity in competitive 
binding with Ethidium bromide has revealed that the binding of o- 
TEBHA with DNA is due to groove binding. Results of molecular 
docking supplemented the experimental results.  
Thankful to UGC-SAP for providing financial support 
REFERENCES 
1. Motlagh M K, Noroozifar M, Khmmarnia S. Fluorescence and 
DNA-binding spectral studies of neodymium (III) complex 
containing 2, 2-bipyridine, [Nd(bpy)2Cl3•OH2
2. Wang Q, Wang X, Yu Z, Yuan X, Jiao K. Spectroscopic and 
Electrochemical Studies on the Binding Mechanism of DNA 
with an Anthraquinone Biological Dye, Nuclear Fast Red. Int J 
Electrochem Sci 2011;6:5470-81. 
]. J 
Spectrochimica Acta Part A 2011;78:389–95. 
3. Zhanga G, Guob J, Zhaob N, Wangb J. Study of interaction 
between kaempferol–Eu3+
4. Zhang, Hu, X, Pan J. Spectoscopic Studies of the interaction 
between primicarb and calf thymus DNA. Guowen 
spectrochimica. J Acta Part A 2011;78:687-94. 
 complex and DNA with the use of the 
Neutral Red dye as a fluorescence probe. J Sens Actuat B 
2010;144:239-46. 
5. Xia J, Chen C, Chen Z, Miele L, Sarkar F H, Wang Z. Targeting 
pancreatic cancer stem cells for cancer therapy. J Biochim 
Biophys Acta 2012;1826:385–399.  
6. Wilson D M, Silverman L N, Bergauer M, Keshari K R. Solid 
phase synthesis of 
7. Hydroxamate peptides for histone deacetylase inhibition. J 
Tetrahedron Let 2013;54:151–3.  
8. Kwak SY, Yang JK, Choi HR, Park KC, Kim YB, Lee YS. Synthesis 
and dual biological effects of hydroxycinnamoyl 
phenylalanyl/prolyl hydroxamic acid derivatives as tyrosinase 
inhibitor and antioxidant. J Bioorg Med Chem Let 
2013;23:1136-42.  
9. Tegoni M, Remelli M. Metallacrowns of copper (II) and 
aminohydroxamates: Thermodynamics of self assembly and 
host guest equilibria. J Coord Chem Rev 2012;256:289– 315.  
10. Samuni Y, Samuni U, Goldstein S. The use of cyclic nitroxide 
radicals as HNO scavengers. J Inorg Biochem 2012;1820:1560-
6.  
11. Zang H, Gates KS. DNA binding and alkylation by the ‘left half’ of 
azinomycin B. J Biochem 2000;39:14968-75. 
12. Tiwari V, Pande R. Molecular Descriptors of N-Arylhydroxamic 
Acids: A Tool in Drug Design. J Chem Biol Drug Des 
2006;68:225–8. 
13. Patre S, Thakur P, Pande R, Solubility and Hydrophobic 
Descriptors of N-Arylhydroxamic Acids. J Biosci Biochem 
Bioinfor 2011;1:267-70. 
14. Vanjari H, Pande R, Hydroxamic acids: proton donor and 
acceptor strength for use in drug design. J Pharma Biomed Anal 
2003;33:783-8. 
15. Agrawal MA, Harjit J, Pande R. Base Strenth and solute-solvent 
Interaction of Metal Extractants: Hydroxamic Acids. J Acta 
Chimica Scand 1999;53:381-6. 
16. Khare D, Pande R. Experimental and molecular docking study 
on DNA binding interaction of N-phenylbenzohydroxamic acid. 
J Der Pharma Chemica 2012;4:66-75. 
17. Rajwade RP, Pande R, Mishra KP, Kumar A, Pandey BN. 
Hydroxamic Acids Analogous Against Breast Cancer Cells: 
2D-QSAR and 3D-QSAR Studies. J QSAR Comb Sci 
2009;28:1500-8. 
18. Kumar A, Rajwade RP, Pandey BN, Pande R, Mishra KP. 
Mechanism of Apoptotic Death In Ehrlich Ascites Tumor Cells 
Induced By Derivatives of Hydroxamic Acid. J of Cell and Tissue 
Res 2007;7:943-8. 
19. Rajwade RP, Pande R, Mishra KP, Kumar A, Pandey BN. 
Quantitative Structure-Activity Relationship (QSAR) of N-
Arylsubstituted Hydroxamic Acids as Inhibitors of Human 
Adenocarinoma Cells A431. J Med Chem 2008;4:237-43. 
Pande et al. 




20. Khare D, Verma B, Pande R. Antioxidant Activity of N-
Phenylbenzohydroxamic Acid. Asian J Pharm Clin Res 
2012;5:121-4. 
21. Roshania R, Agrawal YK. Synthesis of N-Arylhydroxamic acids. J 
Chem Engg Data 1978;23:259-60.  
22. Rajwade RP. Evaluation of lipophilicity, physical parameters 
and antitumor activity of N-arylsubstituted hydroxamic acids, 
Ph. D. Thesis Submitted to Pt. Ravishankar Shukla University, 
Raipur: Chhattisgarh India; 2002.  
23. Agrawal YK, Tandon SG. Preparation and Properties of N-
Arylhydroxamic acid. J Chem Engg Data 1971;16:371. 
24. Gupta VK, Tondon SG. Studies on Hydroxamic Acids 
Preparation and Properties of N-I-naphthylhydroxamic Acids. J 
Chem Engg Data 1972;17:257. 
25. Pande R, Tandon SG. Preparation and properties of N-
arylhydroxamic acids. J Chem Engg Data 1979;24:72-4.  
26. Shahabadi N, Heidari L. Binding studies of the antidiabetic 
drug, metformin to calf thymus DNA using multispectroscopic 
methods. J Spectrochimica Acta Part A 2012;97:406–10.  
27. Satyanarayana S, Cabrowiak JC, Chaires JB. Tris 
(phenanthroline) ruthenium (11) Enantiomer Interactions with 
DNA: Mode and Specificity of Binding. J Biochem 
1993;32:2573–84. 
28. Arjmand F, Parveen S, Afzal M, Shahid M. Synthesis, 
characterization, biological studies (DNA binding, cleavage, 
antibacterial and topoisomerase I) and molecular docking of 
copper (II) benzimidazole complexes. J Photochem Photobio B: 
Bio 2012;114:15–26. 
29. Selvi PT, Evans HS, Palanaindavar M. Synthesis, structure and 
DNA interaction of cobalt(III)bis-complexes of 1,3-bis(2-
pyridylimino)isoindoline and 1,4,7-triazacyclononane. J Inorg 
Biochem 2005;99:2110–8. 
30. Tabassum S, Afzal M, Arjmand F. New heterobimetallic Cu (II)-
Sn2
31. Selvakumar B, Rajendiran V, Maheswari PU, Stoeckli-Evans H. 
Structure spectra and DNA-binding properties of mixed ligand 
copper (II) complexes of iminodiacetic acid, the novel role of 
diamine co-ligands on DNA formation and hydrolytic and 
oxidative double strand DNA cleavage. J Inorg Biochem 
2006;100:316-30. 
 (IV) complex as potential topoisomerase I inhibitor: in vitro 
DNA binding, cleavage and cytotoxicity against human cancer 
cell lines. J Photochem Photobio B: Bio 2012;11:63–72. 
32. Mazzini S, Cristina Bellucci M, Mondelli R. Importance of the 
thiomorpholine introduction in new pyrrole derivatives as 
antimycobacterial agents analogues of BM 212. J Bioorg and 
Med Chem 2003;11:505–14. 
 
